Search - tctmd.com

Displaying 21 - 40 of 9033

Sort: Relevancy | Date

News Conference News ACC 2026

Barbershop Effort Falls Short for Hypertension Prevention in Black Men

Todd Neale

March 29, 2026

News Conference News ACC 2026

Very Low LDL Levels Best in Secondary Prevention: Ez-PAVE

Yael L. Maxwell

March 28, 2026

News Conference News ACC 2026

KARDINAL: Monthly Tonlamarsen May Not Enhance BP Lowering in Resistant Hypertension

Caitlin E. Cox

March 28, 2026

News Conference News ACC 2026

HI-PEITHO: Catheter-Directed Therapy Bests Anticoagulation in Intermediate-Risk PE

L.A. McKeown

March 28, 2026

News Conference News ACC 2026

CHAMPION-AF: A Win for Watchman FLX, but With Caveats

Todd Neale

March 28, 2026

News Conference News ACC 2026

Mechanical Circulatory Support Doesn’t Reduce Infarct Size in STEMI

Michael O'Riordan

March 28, 2026

Presentation ACC 2026

Left Atrial Appendage Closure or Anticoagulation for Atrial Fibrillation: The CHAMPION-AF Clinical Trial

Presenter: Saibal Kar

March 28, 2026

Presentation ACC 2026

Intensive LDL cholesterol targeting in atherosclerotic cardiovascular disease: The Ez-PAVE randomized clinical trial

Presenter: Byeong-Keuk Kim

March 28, 2026

Presentation ACC 2026

Ultrasound-Facilitated Catheter-Directed Thrombolysis vs Anticoagulation Alone for Acute Intermediate-Risk Pulmonary Embolism: Primary Results of the HI-PEITHO Randomized Clinical Trial

Presenter: Stavros V. Konstantinides

March 28, 2026

News Opinion CV Team Dispatch

March 2026 Dispatch for the CV Team

L.A. McKeown

March 26, 2026

News Daily News

Genomics, Lipids, Inflammation at Midlife Predict Future CAD

Caitlin E. Cox

March 25, 2026

News Conference News ACC 2026

What’s Going to Be Hot at ACC 2026

Michael O'Riordan

March 20, 2026

News Daily News

Two Conduction-System Pacing RCTs Give Conflicting Results

Todd Neale

March 20, 2026

News Daily News

Positive Top-line Results for Retatrutide in Diabetes: TRANSCEND-T2D-1

Caitlin E. Cox

March 19, 2026

News Conference News CRT 2026

TAVR-MET: Early Signs Point to Less Postprocedural Valve Dysfunction With Tirzepatide

L.A. McKeown

March 19, 2026

News Daily News

Lp(a) and CAC Levels Independently Predict Long-term ASCVD Risk

Yael L. Maxwell

March 19, 2026

News Daily News

Echocardiographic Surveillance of AS Doesn’t Measure Up to Guidelines

Caitlin E. Cox

March 18, 2026

News Conference News CRT 2026

PARTNER 3: TAVI and SAVR Matched for Health Status at 7 Years

L.A. McKeown

March 17, 2026

News Daily News

Apixaban Bests Rivaroxaban for Bleeding in VTE: COBRRA

Yael L. Maxwell

March 16, 2026

News Conference News CRT 2026

CARPOOL Radial Access as Good as Femoral in PAD Procedures

L.A. McKeown

March 16, 2026

Advertisement

Barbershop Effort Falls Short for Hypertension Prevention in Black Men

Very Low LDL Levels Best in Secondary Prevention: Ez-PAVE

KARDINAL: Monthly Tonlamarsen May Not Enhance BP Lowering in Resistant Hypertension

HI-PEITHO: Catheter-Directed Therapy Bests Anticoagulation in Intermediate-Risk PE

CHAMPION-AF: A Win for Watchman FLX, but With Caveats

Mechanical Circulatory Support Doesn’t Reduce Infarct Size in STEMI

Left Atrial Appendage Closure or Anticoagulation for Atrial Fibrillation: The CHAMPION-AF Clinical Trial

Intensive LDL cholesterol targeting in atherosclerotic cardiovascular disease: The Ez-PAVE randomized clinical trial

Ultrasound-Facilitated Catheter-Directed Thrombolysis vs Anticoagulation Alone for Acute Intermediate-Risk Pulmonary Embolism: Primary Results of the HI-PEITHO Randomized Clinical Trial

March 2026 Dispatch for the CV Team

Genomics, Lipids, Inflammation at Midlife Predict Future CAD

What’s Going to Be Hot at ACC 2026

Two Conduction-System Pacing RCTs Give Conflicting Results

Positive Top-line Results for Retatrutide in Diabetes: TRANSCEND-T2D-1

TAVR-MET: Early Signs Point to Less Postprocedural Valve Dysfunction With Tirzepatide

Lp(a) and CAC Levels Independently Predict Long-term ASCVD Risk

Echocardiographic Surveillance of AS Doesn’t Measure Up to Guidelines

PARTNER 3: TAVI and SAVR Matched for Health Status at 7 Years

Apixaban Bests Rivaroxaban for Bleeding in VTE: COBRRA

CARPOOL Radial Access as Good as Femoral in PAD Procedures

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content